Domtar's Director of Research and Development Bruno Marcoccia discussed his company's new portfolio approach to product development during PaperWeek 2016, explaining that diversifying its product base allows for a certain degree of risk mitigation.
While the company has moved recently towards consumer and bio-products, these continue to be arenas Domtar is cautiously, though enthusiastically, exploring. "To this point we haven't gone in a single, hard direction because the value proposition hasn't arranted it," Macoccia said. "So I would underline that in order to get from product development and demonstration to full commercial deployment, we have quite a lot of work ahead of us."
View the interview conducted by our journalist Mark Williamson at the conference:
For more information on PaperWeek Canada: www.paperweekcanada.ca
